Pregnancy and early embryonic development are periods of particularly high biological demand. Maternal health and the surrounding biological environment can influence early embryonic development. Embryos depend heavily on mitochondria inherited from the maternal oocyte to generate the energy needed for cell development. Maintaining healthy mitochondrial function is therefore particularly important during these earliest stages of life. Conditions associated with inflammation and oxidative stress, such as allergic asthma, may therefore have effects beyond the respiratory system.
New research from Universiti Teknologi MARA (UiTM), Malaysia, provides new insight into this relationship, highlighting a potential link between tocotrienols, maternal inflammatory stress, embryonic mitochondrial health and early developmental outcomes.
Published in Tissue and Cell, the study shows that maternal allergic asthma disrupted mitochondrial structure, dynamics and energy-related pathways in preimplantation embryos. Notably, maternal supplementation with palm tocotrienol-rich fraction (TRF) mitigates several of these changes and was associated with improving early embryonic development in an experimental mouse model.
Using an ovalbumin-induced allergic asthma model in female BALB/c mice, the researchers examined 2-cell embryos for mitochondrial structure, mitochondrial fusion activity, interactions with lipid droplets and the expression of genes involved in mitochondrial energy production.
The research team evaluated the impact of maternal allergic asthma and subsequent TRF supplementation on 2-cell embryos. Key findings include:
Supporting Mitochondrial Fusion: Maternal allergic asthma significantly reduced total mitochondrial volume and fusion activity in 2-cell embryos. Maternal Palm TRF supplementation improved mitochondrial fusion and upregulated the expression of key mitochondrial fusion-related genes, including Mfn1, Mfn2 and Opa1. These changes were associated with improved early embryonic developmental outcomes, highlighting the potential importance of mitochondrial fusion in maintaining mitochondrial function and supporting preimplantation development.
Supporting Energy Supply and Production: Lipid droplets serve as important energy reserves for early embryos, supplying fatty acids that can be utilized by mitochondria to support energy production. The study found that maternal allergic asthma reduced lipid droplet volume and the volume of peridroplet mitochondria (PDM), which are closely associated with lipid droplets. Maternal Palm TRF supplementation partially restored lipid droplet volume and markedly improved PDM volume, suggesting that Palm TRF may help maintain lipid-mitochondrial interactions involved in fatty acid utilization and cellular energy metabolism. The study also found that maternal allergic asthma reduced the expression of Atp5e and Cox4i1, genes associated with mitochondrial ATP production. Maternal TRF supplementation increased the expression of both genes, suggesting that Palm TRF may help support mitochondrial energy-related pathways during early embryonic development.
Associated with Improved Early Embryonic Development: The cellular changes were accompanied by improvements in embryonic developmental potential. Maternal allergic asthma impaired early embryonic development, with only 16% of embryos reaching the blastocyst stage. Maternal Palm TRF supplementation increased the blastocyst formation rate to 54% and the hatched blastocyst rate reached 52%. These findings suggest that maternal Palm TRF supplementation may help support early embryonic development under inflammatory stress.
This study provides new mechanistic insight into how maternal inflammatory stress may influence mitochondrial processes during early embryonic development. By influencing mitochondrial fusion, mitochondria-lipid droplet interactions and ATP synthesis-related pathways, Palm TRF supports mitochondrial resilience and cellular energy metabolism in embryos exposed to maternal inflammatory stress.
“This research adds to the growing evidence highlighting the potential of palm tocotrienols in supporting mitochondrial health”, said Dr. Ariati Aris, Scientific Affairs Specialist at PhytoGaia. “This study provides valuable mechanistic insight into how maternal inflammatory stress may influence mitochondrial function during early embryonic development and highlights the potential beneficial role of palm tocotrienols in maternal nutrition, mitochondrial health and reproductive biology”, added Dr. Ariati Aris.
“Another intriguing perspective on the biological potential of palm tocotrienols, particularly their relationship with mitochondrial resilience and cellular energy metabolism under inflammatory stress,” commented Mr. Bryan See, Vice President of PhytoGaia. “What is particularly interesting is that the study goes beyond the conventional antioxidant narrative and provides mechanistic insights involving mitochondrial fusion, mitochondria–lipid droplet interactions and energy-related pathways. It adds an interesting dimension to the growing scientific understanding of tocotrienols.”
“At PhytoGaia, we are committed to supporting science-driven innovation around tocotrienols. Our TocoGaia® – natural palm tocotrienol complex – is available in various forms and can be incorporated into a range of product formats and dosages. At the same time, we very much welcome research collaborations to further explore the biological potential and health applications of tocotrienols, helping to advance both science and science-driven product development,” he added.
Disclaimer: The statements in the above article have not been evaluated by the Food and Drug Administration. They are not intended to diagnose, treat, cure or prevent any disease.
Reference:
Wafriy CI, et al. Maternal tocotrienol supplementation protects early embryo mitochondria from allergic asthma stress. Tissue Cell. 2026 Aug;101:103474.
